Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Phase 1 Results of ZUMA-3: KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)

Bijal D. Shah, MD, Wendy Stock, MD, William G Wierda, MD PhD, Olalekan Oluwole, MBBS, MPH, Houston Holmes, MD FACP, Gary J. Schiller, MD FACP, Max S. Topp, MD, Marie José Kersten, MD PhD, Roch Houot, MD PhD, Nicolas Boissel, MD PhD, Michelle Mojadidi, MSc, Allen Xue, PhD, Armen Mardiros, PhD, Yizhou Jiang, PhD, Tong Shen, PhD, Jeff S. Aycock, Shanna Stout, Jeffrey S. Wiezorek, MD MS, Rajul Jain, MD

Blood (2017) 130 (Supplement 1): 888.

https://doi.org/10.1182/blood.V130.Suppl_1.888.888

Published: 2017

Journal Articles

Cladribine for the Management of Erdheim-Chester Histiocytosis in Adults

Harsh Patel, Cary Kraft, Gary J. Schiller, MD FACP

Blood (2014) 124 (21): 5551.

https://doi.org/10.1182/blood.V124.21.5551.5551

Published: 2014

Journal Articles

Phase 3 Study Of Pomalidomide In Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis With RBC-Transfusion-Dependence

Ayalew Tefferi, MD, Francesco Passamonti, MD, Tiziano Barbui, MD, Giovanni Barosi, MD, Kebede Begna, MD, Mario Cazzola, Francisco Cervantes, MD, PhD, Konstanze Döhner, M.D., Heinz Gisslinger, MD, Vikas Gupta, MD, MRCP, FRCPath, Wang Li, C N Harrison, Jean-Jacques Kiladjian, Mary Frances McMullin, MD, MRCPath, Alessandro Rambaldi, MD, Gary J. Schiller, MD, FACP, Alessandro M Vannucchi, MD, Ruben A. Mesa, MD

Blood (2013) 122 (21): 394.

https://doi.org/10.1182/blood.V122.21.394.394

Published: 2013

Journal Articles

Autologous Stem Cell Transplant in Patients with Multiple Myeloma Previously Treated with Lenalidomide: A Single-Institution Experience Using An Intermediate-Dose Cyclophosphamide-Based Regimen

Asif Alavi, Rada Grubovic, Gary J. Schiller, MD, FACP

Blood (2011) 118 (21): 4391.

https://doi.org/10.1182/blood.V118.21.4391.4391

Published: 2011

Journal Articles

Preliminary Results of a Multicenter Phase II Trial of 5-Day Decitabine as Front-Line Therapy for Elderly Patients with Acute Myeloid Leukemia (AML)

Amanda F Cashen, MD, Gary J. Schiller, MD, FACP, Margaret R. O’Donnell, MD, Julie S. Larsen, PharmD, Akhil Baranwal, MD, Michael T Cullen, MD, John F DiPersio, MD, PhD

Blood (2008) 112 (11): 560.

https://doi.org/10.1182/blood.V112.11.560.560

Published: 2008

Journal Articles

Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome : Results of a Randomized Comparative Phase III Study.

Jorge Cortes, MD, Karen Seiter, MD, Richard Thomas Maziarz, MD, Meir Wetzler, MD, Michael Craig, MD, Jeffrey Matous, Selina Luger, MD, Bimalangshu Dey, MD, Gary J. Schiller, MD, FACP, Dat Pham, MD, Camille N. Abboud, MD, FACP, Muthuswamy Krishnamurthy, MD, Archie Brown, Jr., MD, Joseph O. Moore, MD

Blood (2008) 112 (11): 919.

https://doi.org/10.1182/blood.V112.11.919.919

Published: 2008

Journal Articles

Phase 1/2 Trial of the XIAP Antisense Oligonucleotide (AEG35156) in Combination with Idarubicin and Cytarabine in Patients with Relapsed/Refractory AML

Aaron D Schimmer, MD, PhD, FRCPC, Elihu H Estey, MD, Gautam Borthakur, MD, Bing Carter, PhD, Gary J. Schiller, MD, FACP, Martin S. Tallman, MD, Jessica K Altman, Judith E. Karp, MD, Jeannine Kassis, MD, FRCP, Christine Jacob, MSc, Stephen Morris, Jacques Jolivet, MD, FRCP(C), Michael Andreeff, MD, PhD

Blood (2008) 112 (11): 764.

https://doi.org/10.1182/blood.V112.11.764.764

Published: 2008

NARROW

Phase 1 Results of ZUMA-3: KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)

Cladribine for the Management of Erdheim-Chester Histiocytosis in Adults

Phase 3 Study Of Pomalidomide In Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis With RBC-Transfusion-Dependence

Autologous Stem Cell Transplant in Patients with Multiple Myeloma Previously Treated with Lenalidomide: A Single-Institution Experience Using An Intermediate-Dose Cyclophosphamide-Based Regimen

Preliminary Results of a Multicenter Phase II Trial of 5-Day Decitabine as Front-Line Therapy for Elderly Patients with Acute Myeloid Leukemia (AML)

Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome : Results of a Randomized Comparative Phase III Study.

Phase 1/2 Trial of the XIAP Antisense Oligonucleotide (AEG35156) in Combination with Idarubicin and Cytarabine in Patients with Relapsed/Refractory AML

Email alerts

ASH Publications

American Society of Hematology

Phase 1 Results of ZUMA-3: KTE-C19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia (R/R ALL)

Cladribine for the Management of Erdheim-Chester Histiocytosis in Adults

Phase 3 Study Of Pomalidomide In Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis With RBC-Transfusion-Dependence

Autologous Stem Cell Transplant in Patients with Multiple Myeloma Previously Treated with Lenalidomide: A Single-Institution Experience Using An Intermediate-Dose Cyclophosphamide-Based Regimen

Preliminary Results of a Multicenter Phase II Trial of 5-Day Decitabine as Front-Line Therapy for Elderly Patients with Acute Myeloid Leukemia (AML)

Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome : Results of a Randomized Comparative Phase III Study.

Phase 1/2 Trial of the XIAP Antisense Oligonucleotide (AEG35156) in Combination with Idarubicin and Cytarabine in Patients with Relapsed/Refractory AML

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only